Cameron, D A <br/><br/>
Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  May 2000 
 - 845-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/s0959-8049(00)00013-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antigens, Neoplasm--metabolism<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--drug therapy<br/>Cell Division--drug effects<br/>DNA Topoisomerases, Type II<br/>DNA-Binding Proteins<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Mitosis--drug effects<br/>Nuclear Proteins--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Tamoxifen--therapeutic use<br/>Time Factors